BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 32997095)

  • 1. Five-Year Health Status After Self-expanding Transcatheter or Surgical Aortic Valve Replacement in High-risk Patients With Severe Aortic Stenosis.
    Arnold SV; Chinnakondepalli KM; Magnuson EA; Reardon MJ; Deeb GM; Gleason T; Yakubov SJ; Cohen DJ;
    JAMA Cardiol; 2021 Jan; 6(1):97-101. PubMed ID: 32997095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial.
    Baron SJ; Arnold SV; Wang K; Magnuson EA; Chinnakondepali K; Makkar R; Herrmann HC; Kodali S; Thourani VH; Kapadia S; Svensson L; Brown DL; Mack MJ; Smith CR; Leon MB; Cohen DJ;
    JAMA Cardiol; 2017 Aug; 2(8):837-845. PubMed ID: 28658491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
    Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
    JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
    Osnabrugge RL; Arnold SV; Reynolds MR; Magnuson EA; Wang K; Gaudiani VA; Stoler RC; Burdon TA; Kleiman N; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Feb; 8(2):315-323. PubMed ID: 25700755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in the Randomized CoreValve US Pivotal High Risk Trial in Patients With a Society of Thoracic Surgeons Risk Score of 7% or Less.
    Reardon MJ; Kleiman NS; Adams DH; Yakubov SJ; Coselli JS; Deeb GM; O'Hair D; Gleason TG; Lee JS; Hermiller JB; Chetcuti S; Heiser J; Merhi W; Zorn GL; Tadros P; Robinson N; Petrossian G; Hughes GC; Harrison JK; Maini B; Mumtaz M; Conte JV; Resar JR; Aharonian V; Pfeffer T; Oh JK; Huang J; Popma JJ
    JAMA Cardiol; 2016 Nov; 1(8):945-949. PubMed ID: 27541162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
    Arnold SV; Reynolds MR; Wang K; Magnuson EA; Baron SJ; Chinnakondepalli KM; Reardon MJ; Tadros PN; Zorn GL; Maini B; Mumtaz MA; Brown JM; Kipperman RM; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1207-1217. PubMed ID: 26292584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy Registry.
    Arnold SV; Spertus JA; Vemulapalli S; Li Z; Matsouaka RA; Baron SJ; Vora AN; Mack MJ; Reynolds MR; Rumsfeld JS; Cohen DJ
    JAMA Cardiol; 2017 Apr; 2(4):409-416. PubMed ID: 28146260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Outcomes After Transcatheter Aortic Valve Replacement vs Surgical Aortic Valve Replacement Among Patients With Aortic Stenosis at Low Operative Risk.
    Virtanen MPO; Eskola M; Jalava MP; Husso A; Laakso T; Niemelä M; Ahvenvaara T; Tauriainen T; Maaranen P; Kinnunen EM; Dahlbacka S; Jaakkola J; Vasankari T; Airaksinen J; Anttila V; Rosato S; D'Errigo P; Savontaus M; Juvonen T; Laine M; Mäkikallio T; Valtola A; Raivio P; Biancari F
    JAMA Netw Open; 2019 Jun; 2(6):e195742. PubMed ID: 31199448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy.
    Gada H; Kirtane AJ; Wang K; Lei Y; Magnuson E; Reynolds MR; Williams MR; Kodali S; Vahl TP; Arnold SV; Leon MB; Thourani V; Szeto WY; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2015 Jul; 8(4):338-46. PubMed ID: 26058718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).
    Skelding KA; Yakubov SJ; Kleiman NS; Reardon MJ; Adams DH; Huang J; Forrest JK; Popma JJ
    Am J Cardiol; 2016 Aug; 118(4):560-6. PubMed ID: 27381665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis.
    Baron SJ; Magnuson EA; Lu M; Wang K; Chinnakondepalli K; Mack M; Thourani VH; Kodali S; Makkar R; Herrmann HC; Kapadia S; Babaliaros V; Williams MR; Kereiakes D; Zajarias A; Alu MC; Webb JG; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2019 Dec; 74(23):2833-2842. PubMed ID: 31577923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.
    Baron SJ; Arnold SV; Reynolds MR; Wang K; Deeb M; Reardon MJ; Hermiller J; Yakubov SJ; Adams DH; Popma JJ; Cohen DJ;
    Am Heart J; 2017 Dec; 194():39-48. PubMed ID: 29223434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Short and Mid-Term Mortality and Morbidity in Patients With Severe Aortic Stenosis (Intermediate/High Risk) Who Underwent Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement.
    Yesiltas MA; Haberal İ; Kuserli Y; Yildiz A; Koyuncu AO; Özsoy SD
    Heart Surg Forum; 2020 Apr; 23(2):E212-E220. PubMed ID: 32364917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Hemodynamics of Transcatheter and Surgical Aortic Valves in the PARTNER Trial.
    Douglas PS; Leon MB; Mack MJ; Svensson LG; Webb JG; Hahn RT; Pibarot P; Weissman NJ; Miller DC; Kapadia S; Herrmann HC; Kodali SK; Makkar RR; Thourani VH; Lerakis S; Lowry AM; Rajeswaran J; Finn MT; Alu MC; Smith CR; Blackstone EH;
    JAMA Cardiol; 2017 Nov; 2(11):1197-1206. PubMed ID: 28973520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-Year Clinical and Quality of Life Outcomes From the CoreValve US Pivotal Extreme Risk Trial.
    Arnold SV; Petrossian G; Reardon MJ; Kleiman NS; Yakubov SJ; Wang K; Hermiller J; Harrison JK; Deeb GM; Huang J; Cohen DJ;
    Circ Cardiovasc Interv; 2021 Jun; 14(6):e010258. PubMed ID: 34092091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis.
    Reynolds MR; Magnuson EA; Lei Y; Leon MB; Smith CR; Svensson LG; Webb JG; Babaliaros VC; Bowers BS; Fearon WF; Herrmann HC; Kapadia S; Kodali SK; Makkar RR; Pichard AD; Cohen DJ;
    Circulation; 2011 Nov; 124(18):1964-72. PubMed ID: 21969017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.